mhurhangee/ep-ind-claims huggingface dataset:
A communication system comprising: a communication unit configured to receive, from a communication source (1a, 1b), a scheduling request for scheduling transmission of a message to a specific communication destination (1a, 1b); and a control unit configured to perform control such that the message is transmitted to the communication destination (1a, 1b) at an appropriate time slot in accordance with content of the message and a current and past psychological situation of a user corresponding to the specific communication destination received by the communication unit, wherein the control unit is configured to determine the appropriate time slot for transmitting the message to communication destination (1a, 1b) in accordance with the current psychological situation of the user which is estimated on a basis of a schedule of the user or weather forecast information in a transmission period designated by the communication source (1a, 1b), and in accordance with the content of the message received from the communication source (1a, 1b), and in accordance with a relation between content of a past message received by the user and the corresponding past psychological situation, wherein the past psychological situation of the user is estimated on a basis of a result of a questionnaire answered by the user; or wherein the past psychological situation of the user at the time of receiving the message is estimated on a basis of change in heartbeats of the user before and after receiving the message. a communication unit configured to receive, from a communication source (1a, 1b), a scheduling request for scheduling transmission of a message to a specific communication destination (1a, 1b); and a control unit configured to perform control such that the message is transmitted to the communication destination (1a, 1b) at an appropriate time slot in accordance with content of the message and a current and past psychological situation of a user corresponding to the specific communication destination received by the communication unit, wherein the control unit is configured to determine the appropriate time slot for transmitting the message to communication destination (1a, 1b) in accordance with the current psychological situation of the user which is estimated on a basis of a schedule of the user or weather forecast information in a transmission period designated by the communication source (1a, 1b), and in accordance with the content of the message received from the communication source (1a, 1b), and in accordance with a relation between content of a past message received by the user and the corresponding past psychological situation, wherein the past psychological situation of the user is estimated on a basis of a result of a questionnaire answered by the user; or wherein the past psychological situation of the user at the time of receiving the message is estimated on a basis of change in heartbeats of the user before and after receiving the message.
A method for desulfurizing hot metal by analyzing S concentration of a sample taken out from the hot metal in at least one stage before, during and after desulfurization treatment of the hot metal, and conducting further subsequent desulfurization or judging an end of desulfurization or determining subsequent desulfurization conditions based on an analyzed value of S concentration, characterised in that the S concentration is analysed by a method which comprises a high frequency induction heating step of oxidizing the sample under a high frequency induction heating in a pure oxygen atmosphere, which has an oxygen concentration of not less than 99.5 vol.-% so as to render an oxygen concentration in SO 2 -containing gas produced by combustion of the sample into not less than 90 vol.-%, to convert S in the hot metal to SO 2 and an analysis step of analyzing SO 2 -containing gas generated in the high frequency induction heating step through an ultraviolet fluorescence method to quantify S concentration in the sample.
Use as a shampoo of a formulation comprising: at least one surfactant of Formula I, wherein R 1 and R 2 may be the same or different, and may be selected from the group consisting of hydrogen and C 1 -C 6 alkyl, wherein the C 1 -C 6 alkyl may optionally be substituted with one or more substituents selected from the group consisting of hydroxyl, amino, amido, sulfonyl, sulfonate, carbonyl, carboxyl, and carboxylate; n is 5; m is an integer from 9 to 20 (including 9 and 20); the terminal nitrogen is optionally further substituted with R 3, wherein R 3 is selected from the group consisting of hydrogen, oxygen, hydroxyl, and C 1 -C 6 alkyl, wherein the C 1 -C 6 alkyl may optionally be substituted with one or more substituents selected from the group consisting of hydroxyl, amino, amido, sulfonyl, sulfonate, carbonyl, carboxyl, and carboxylate; an optional counterion associated with the compound which, if present, is selected from the group consisting of chloride, bromide, iodide, and hydroxide; at least one of a foaming agent, a foam booster, and a thickener; and water. at least one surfactant of Formula I, wherein R 1 and R 2 may be the same or different, and may be selected from the group consisting of hydrogen and C 1 -C 6 alkyl, wherein the C 1 -C 6 alkyl may optionally be substituted with one or more substituents selected from the group consisting of hydroxyl, amino, amido, sulfonyl, sulfonate, carbonyl, carboxyl, and carboxylate; n is 5; m is an integer from 9 to 20 (including 9 and 20); the terminal nitrogen is optionally further substituted with R 3, wherein R 3 is selected from the group consisting of hydrogen, oxygen, hydroxyl, and C 1 -C 6 alkyl, wherein the C 1 -C 6 alkyl may optionally be substituted with one or more substituents selected from the group consisting of hydroxyl, amino, amido, sulfonyl, sulfonate, carbonyl, carboxyl, and carboxylate; an optional counterion associated with the compound which, if present, is selected from the group consisting of chloride, bromide, iodide, and hydroxide; at least one of a foaming agent, a foam booster, and a thickener; and water.
An air-conditioner indoor unit (10, 30, 80) comprising, in a case main body embedded in a ceiling, an indoor heat exchanger, a drain pan, an air-blower driving motor, an air blower, and an air deflector, wherein the drain pan has a through-hole passing therethrough in a plate thickness direction, and a transparent member is fitted in the through-hole, characterized in that a plate-like reflecting plate (20, 31) is provided directly above the through-hole and the transparent member and higher than the maximum water level of drainage in such a manner that the upper surface and the lower surface thereof are substantially parallel to a horizontal surface.
A medical device (100, 200) comprising: a communication module (102, 202) configured to deliver a plurality of pulses to tissue of a patient, where each pulse comprises an amount of energy; a control module (110, 210) operatively coupled to the communication module, the control module configured to: for each delivered pulse, determine whether the delivered pulse produces an unwanted stimulation of the patient; change the amount of energy of the plurality of pulses over time so as to identify an amount of energy that corresponds to an unwanted stimulation threshold for the pulses; set a maximum energy value for communication pulses that is below the unwanted stimulation threshold; and deliver communication pulses below the maximum energy value during communication with another medical device. a communication module (102, 202) configured to deliver a plurality of pulses to tissue of a patient, where each pulse comprises an amount of energy; a control module (110, 210) operatively coupled to the communication module, the control module configured to: for each delivered pulse, determine whether the delivered pulse produces an unwanted stimulation of the patient; change the amount of energy of the plurality of pulses over time so as to identify an amount of energy that corresponds to an unwanted stimulation threshold for the pulses; set a maximum energy value for communication pulses that is below the unwanted stimulation threshold; and deliver communication pulses below the maximum energy value during communication with another medical device. for each delivered pulse, determine whether the delivered pulse produces an unwanted stimulation of the patient; change the amount of energy of the plurality of pulses over time so as to identify an amount of energy that corresponds to an unwanted stimulation threshold for the pulses; set a maximum energy value for communication pulses that is below the unwanted stimulation threshold; and deliver communication pulses below the maximum energy value during communication with another medical device.
Spinal cord stimulation system which comprises: a. An electrode with a diameter ≤ 1.3 mm, consisting essentially of a plurality of poles, suitable for being inserted inside the intradural space; b. Unit, connected to the electrode, configured to systematically read the impedance of the poles when the electrode is going through the dura matter, and to generate electric current; and c. A computer comprising a processing unit configured to: i. Receive, from the unit, continuous impedance readings of each pole when the electrode is going through the dura matter, ii. Process the impedance readings received for finding a statistically significant variation or deviation of the impedance, and iii. Wherein the computer comprising a processing unit is characterized in that it is further configured to provide an output through a terminal and give instructions to unit to apply electric current inside the intradural space, when a statistically significant reduction of the impedance of a specific pole is identified, which indicates that the pole has gone through the dura mater and is placed in the intradural space at the inner part of the dura mater-arachnoid. a. An electrode with a diameter ≤ 1.3 mm, consisting essentially of a plurality of poles, suitable for being inserted inside the intradural space; b. Unit, connected to the electrode, configured to systematically read the impedance of the poles when the electrode is going through the dura matter, and to generate electric current; and c. A computer comprising a processing unit configured to: i. Receive, from the unit, continuous impedance readings of each pole when the electrode is going through the dura matter, ii. Process the impedance readings received for finding a statistically significant variation or deviation of the impedance, and iii. Wherein the computer comprising a processing unit is characterized in that it is further configured to provide an output through a terminal and give instructions to unit to apply electric current inside the intradural space, when a statistically significant reduction of the impedance of a specific pole is identified, which indicates that the pole has gone through the dura mater and is placed in the intradural space at the inner part of the dura mater-arachnoid. i. Receive, from the unit, continuous impedance readings of each pole when the electrode is going through the dura matter, ii. Process the impedance readings received for finding a statistically significant variation or deviation of the impedance, and iii. Wherein the computer comprising a processing unit is characterized in that it is further configured to provide an output through a terminal and give instructions to unit to apply electric current inside the intradural space, when a statistically significant reduction of the impedance of a specific pole is identified, which indicates that the pole has gone through the dura mater and is placed in the intradural space at the inner part of the dura mater-arachnoid.
An anti-α4β7 humanized antibody for use in a method for the therapeutic treatment of inflammatory bowel disease, wherein the anti-α4β7 humanized antibody is to be administered to a patient suffering from inflammatory bowel disease, wherein the anti-α4β7 humanized antibody is administered to the patient according to the following dosing regimen: a. an initial dose of 300 mg of the anti-α4β7 humanized antibody as an intravenous infusion; b. followed by a second subsequent dose of 300 mg of the anti-α4β7 humanized antibody as an intravenous infusion at two weeks after the initial dose; c. followed by a third subsequent dose of 300 mg of the anti-α4β7 humanized antibody as an intravenous infusion at six weeks after the initial dose; d. followed by a fourth and subsequent doses of 300 mg of the anti-α4β7 humanized antibody as an intravenous infusion every four weeks or every eight weeks after the third subsequent dose of the humanized antibody as needed; wherein the dosing regimen induces a clinical response and clinical remission in the inflammatory bowel disease of the patient; wherein the anti-α4β7 humanized antibody is vedolizumab, and further wherein the inflammatory bowel disease is moderately to severely active ulcerative colitis or moderately to severely active Crohn's Disease. a. an initial dose of 300 mg of the anti-α4β7 humanized antibody as an intravenous infusion; b. followed by a second subsequent dose of 300 mg of the anti-α4β7 humanized antibody as an intravenous infusion at two weeks after the initial dose; c. followed by a third subsequent dose of 300 mg of the anti-α4β7 humanized antibody as an intravenous infusion at six weeks after the initial dose; d. followed by a fourth and subsequent doses of 300 mg of the anti-α4β7 humanized antibody as an intravenous infusion every four weeks or every eight weeks after the third subsequent dose of the humanized antibody as needed; wherein the dosing regimen induces a clinical response and clinical remission in the inflammatory bowel disease of the patient; wherein the anti-α4β7 humanized antibody is vedolizumab, and further wherein the inflammatory bowel disease is moderately to severely active ulcerative colitis or moderately to severely active Crohn's Disease. wherein the dosing regimen induces a clinical response and clinical remission in the inflammatory bowel disease of the patient; wherein the anti-α4β7 humanized antibody is vedolizumab, and further wherein the inflammatory bowel disease is moderately to severely active ulcerative colitis or moderately to severely active Crohn's Disease.
Device for actuating a control surface of an aircraft, comprising: - a frame intended to be mounted fixed in relation to a structure of an aircraft, - a bell crank part mobile in rotation in relation to the frame around an axis of rotation and adapted in order to be comprised in a mechanical unit for displacement of the control surface, - a slider intended to be connected to a drive member, the slider being mobile in translation in relation to the frame according to a direction of translation, parallel to the axis of rotation of the bell crank part, - first connecting means between the slider and the bell crank part, the first connecting means including first helical grooves arranged on a first portion of the slider and cooperating with additional helical grooves of the bell crank part, in order to convert a displacement in translation of the slider generated by the drive member into a displacement in rotation of the bell crank part, in order to actuate the mechanical unit for displacement of the control surface, characterized in that the slider comprises a cylindrical body comprising the helical grooves for the circulation of balls formed on an external cylindrical surface of the body and internal channels for the recirculation of balls formed inside the body making it possible to carry balls removed at the output of the circulation grooves in order to reintroduce them at the input of the circulation grooves. - a frame intended to be mounted fixed in relation to a structure of an aircraft, - a bell crank part mobile in rotation in relation to the frame around an axis of rotation and adapted in order to be comprised in a mechanical unit for displacement of the control surface, - a slider intended to be connected to a drive member, the slider being mobile in translation in relation to the frame according to a direction of translation, parallel to the axis of rotation of the bell crank part, - first connecting means between the slider and the bell crank part, the first connecting means including first helical grooves arranged on a first portion of the slider and cooperating with additional helical grooves of the bell crank part, in order to convert a displacement in translation of the slider generated by the drive member into a displacement in rotation of the bell crank part, in order to actuate the mechanical unit for displacement of the control surface,
Remote-controllable working device, comprising a signal-receiving apparatus which is fastened in an elastically movable manner to the working device, wherein - the signal-receiving apparatus is held by an elastically deformable carrier on a housing of the working device, - the carrier is connected at at least one fastening point (7, 8) to the housing such that, when a force acts upon the signal-receiving apparatus, the connection between the carrier and the housing at the fastening point (7, 8) can be released by reason of an elastic deformation of the carrier so that the carrier with the signal-receiving apparatus can be moved into the interior of the housing, - the carrier is connected at at least two fastening points to the housing, - a pivot axis is formed at a first one of the fastening points (4, 7), the carrier with the signal-receiving apparatus being able to be pivoted about said pivot axis if the force is exerted upon the signal-receiving apparatus, and wherein - at the second one of the fastening points (5, 8) the carrier is releasably fastened to the housing such that, when the force acts upon the signal-receiving apparatus, the connection between the carrier and the housing at this fastening point (5, 8) can be released by reason of an elastic deformation of the carrier. - the signal-receiving apparatus is held by an elastically deformable carrier on a housing of the working device, - the carrier is connected at at least one fastening point (7, 8) to the housing such that, when a force acts upon the signal-receiving apparatus, the connection between the carrier and the housing at the fastening point (7, 8) can be released by reason of an elastic deformation of the carrier so that the carrier with the signal-receiving apparatus can be moved into the interior of the housing, - the carrier is connected at at least two fastening points to the housing, - a pivot axis is formed at a first one of the fastening points (4, 7), the carrier with the signal-receiving apparatus being able to be pivoted about said pivot axis if the force is exerted upon the signal-receiving apparatus, and wherein - at the second one of the fastening points (5, 8) the carrier is releasably fastened to the housing such that, when the force acts upon the signal-receiving apparatus, the connection between the carrier and the housing at this fastening point (5, 8) can be released by reason of an elastic deformation of the carrier.
A board book for use in an augmented reality system, comprising: a plurality of stiff leaves (1001, 1002, 1004), each side of which forms a page of the book, and in which each such page comprises a fiduciary marker (1011, 1012, 1014); and a cover having larger dimensions than said leaves of the book, and hence having extremities that extend beyond the outer edges of said pages; and in which the inside of the cover comprises a first high contrast pattern (1030A,B,C,D) along at least a first such extremity; characterised in that said first high contrast pattern comprises black and white blocks, or blocks of two contrasting colours or colour tones, thereby encoding a linear binary code along said extremity. a plurality of stiff leaves (1001, 1002, 1004), each side of which forms a page of the book, and in which each such page comprises a fiduciary marker (1011, 1012, 1014); and a cover having larger dimensions than said leaves of the book, and hence having extremities that extend beyond the outer edges of said pages; and in which the inside of the cover comprises a first high contrast pattern (1030A,B,C,D) along at least a first such extremity;
A protection shield for handguns comprising: a transparent or translucid shield made of ballistic material, or non-ballistic material, being that in the center of the shield it is provided a pass-through aperture of a big enough size so that it can be transpierced by the barrel and a portion of the gun's frame; wherein the shield also comprises a handgun coupling, the coupling comprising a block having on its upper portion a groove for receiving a gun rail and on its lower portion a rail projecting crosswise in relation to the shield's plane for the coupling of accessories such as: gun sights, flashlight, laser aims or others; and wherein the coupling is fixedly mounted on the front face of the shield, on the lower portion of the shield's pass-through aperture. a transparent or translucid shield made of ballistic material, or non-ballistic material, being that in the center of the shield it is provided a pass-through aperture of a big enough size so that it can be transpierced by the barrel and a portion of the gun's frame; wherein the shield also comprises a handgun coupling, the coupling comprising a block having on its upper portion a groove for receiving a gun rail and on its lower portion a rail projecting crosswise in relation to the shield's plane for the coupling of accessories such as: gun sights, flashlight, laser aims or others; and wherein the coupling is fixedly mounted on the front face of the shield, on the lower portion of the shield's pass-through aperture.
A low-oxygen clean steel consisting of, as chemical components, by mass %, 1.20% or less of C, 3.00% or less of Si, 16.0% or less of Mn, 0,05% or less of P, 0.05% or less of S, 0.005% to 0.20% of Al, greater than 0% to 0.0005% of Ca, 0.00005% to 0.0004% of REM, and greater than 0% to 0.003% of T.O; and optionally one or two or more of 3.50% or less of Cr, 0.85% or less of Mo, 4.50% or less of Ni, 0.20% or less of Nb, 0.45% or less of V, 0.30% or less of W, 0.006% or less of B, 0.06% or less of N, 0.25% or less of Ti, 0.50% or less of Cu, 0.45% or less of Pb, 0.20% or less of Bi, 0.01% or less of Te, 0.20% or less of Sb, and 0.01% or less of Mg; with the remainder being Fe and impurities, wherein the REM content, the Ca content, and the T.O content satisfy the following Expressions 1 and 2, nonmetallic inclusions which have a maximum predicted diameter of 1 μm to 30 μm measured using an extreme value statistical method under the condition in which a prediction area is 30,000 mm 2, and contain Al 2 O 3 and REM oxide are dispersed in the steel, an average proportion of the Al 2 O 3 in the nonmetallic inclusions is greater than 50%, the REM is one or two or more of rare-earth elements La, Ce, Pr, and Nd, T.O is a total amount of the dissolved oxygen in the steel and the undissolved oxygen contained in the inclusions, and the steel is Al-deoxidized steel or Al-Si-deoxidized steel, 0.15 ≤ REM / Ca ≤ 4.00 Ca / T. O ≤ 0.50 wherein the REM content, the Ca content, and the T.O content satisfy the following Expressions 1 and 2, nonmetallic inclusions which have a maximum predicted diameter of 1 μm to 30 μm measured using an extreme value statistical method under the condition in which a prediction area is 30,000 mm 2, and contain Al 2 O 3 and REM oxide are dispersed in the steel, an average proportion of the Al 2 O 3 in the nonmetallic inclusions is greater than 50%, the REM is one or two or more of rare-earth elements La, Ce, Pr, and Nd, T.O is a total amount of the dissolved oxygen in the steel and the undissolved oxygen contained in the inclusions, and the steel is Al-deoxidized steel or Al-Si-deoxidized steel, 0.15 ≤ REM / Ca ≤ 4.00 Ca / T. O ≤ 0.50
A process for the production of an at least two-layer sheet via adhesive bonding of at least one thinner thermoplastic foam sheet and of at least one thinner sheet, where the thinner sheet has been produced from a material with average cell diameter ≤ 1000 nm.